Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-19

Clinical Trial Update: Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial evaluating intensity-modulated radiation therapy for patients with stage I–IV prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intensity-Modulated Radiation Therapy

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED